Loading clinical trials...
Loading clinical trials...
HFpEF has gradually become the most common form of heart failure. Studies have found that metabolic abnormalities and chronic inflammation ultimately lead to HFpEF by promoting heart remodeling. Howev...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chongqing Medical University
NCT04913805 · Heart Failure With Preserved Ejection Fraction
NCT06762964 · Fontan Circulation, Single Ventricle Heart Disease, and more
NCT07560436 · Heart Failure With Preserved Ejection Fraction (HFPEF), Coronary Artery Disease
NCT07083011 · Heart Failure With Preserved Ejection Fraction
NCT07037459 · Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, and more
The First Affiliated Hospital of Chongqing Medical University
Chongqing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions